Hyaluronidase/rituximab - Roche
At a glance
- Drug Originator Roche
- Drug Class Antineoplastics; Glycoside hydrolases; Monoclonal antibodies; Polysaccharide lyases
- Mechanism of Action Antibody-dependent cell cytotoxicity; Cell death stimulants; Immunostimulants
- USA Patent Applicants GENENTECH INC
- USA Patents 739
- BLAs 1
- International Patents 9,494

Disclaimer